Search results

The Department of Health has agreed that the August Drug Tariff Part VIIIA reimbursement price for the following items will be: Lorazepam 2.5mg tablets £6.50 Ropinirole 2mg tablets £34.50 Ropinirole 5mg tablets £175.00  and not as printed in…

The Department of Health has agreed that the November Drug Tariff Part VIIIA reimbursement price for the following items will be: Ropinirole 5mg tablets £160.00 Valsartan 40mg capsules £4.90 Valsartan 80mg capsules £4.14 and not as printed in…

The Department of Health has agreed that the December Drug Tariff Part VIIIA reimbursement price for the following items will be:  Flecainide 100mg tablets £13.60 Leflunomide 20mg tablets £10.99 Trospium chloride 20mg tablets £15.47 and not…

The Department of Health has agreed that the January Drug Tariff Part VIIIA reimbursement price for the following items will be: Leflunomide 10mg tablets £8.20 Leflunomide 20mg tablets £9.50 Ropinirole 2mg tablets £25.00 Zolmitriptan 2.5mg…

The Department of Health has agreed that the February Drug Tariff Part VIIIA reimbursement prices for the following items will be: Buspirone 5mg tablets £17.50 Leflunomide 10mg tablets £7.79 Leflunomide 20mg tablets £9.03 Valsartan 40mg…

The Department of Health has agreed that the March Drug Tariff Part VIIIA reimbursement price for the following items will be: Buspirone 5mg tablets £16.50 Leflunomide 10mg tablets £7.76 Leflunomide 20mg tablets £8.90 Nitrofurantoin 100mg…

The Department of Health has agreed that the April Drug Tariff Part VIIIA reimbursement price for the following items will be: Clindamycin 150mg capsules £4.85 Flecainide 50mg tablets £11.57 Leflunomide 20mg tablets £8.16 and not as printed in…

Drug Tariff Part VIIA: Quality Payments Scheme (England): Correction Contractors should be made aware that paragraph 2.1 of Part VIIA in the October Drug Tariff should read: “There will be one review on 15 February 2019, at which quality payments…

The Department of Health and Social Care with the Pharmaceutical Services Negotiating Committee’s agreement is maintaining CPCF funding for 2018/19  at the same level as last year, i.e. £2.592 billion. In order to deliver this level of funding the…

Guidance for manufacturers and suppliers of medicines, oxygen and appliances. This includes: updating us on product details and price information through Medicines Data - dm+d access to the home oxygen therapy application information on…